Curcumin in Alzheimer's Disease and Depression: Therapeutic Potential and Mechanisms of Action

被引:4
|
作者
Oliveira, Jordan Teixeira [1 ]
Pieniz, Simone [1 ]
机构
[1] Univ Fed Pelotas, Dept Nutr, Pelotas, RS, Brazil
关键词
Curcuma longa; turmeric; polyphenol; BDNF; Dementia; neurological disease; TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; OXIDATIVE DAMAGE; MESSENGER-RNA; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; RATS INVOLVEMENT; SMALL-INTESTINE; BDNF LEVELS;
D O I
10.1590/1678-4324-2024220004
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Curcumin is a polyphenol present in Curcuma longa, a root used in Asian cuisine for thousands of years, and it has several medicinal properties, acting as an antioxidant, anti-inflammatory, anticancer, among others. Polyphenols generally have the ability to restore BDNF (Brain Derived Neurotrophic Factor) levels, which is a very important neurotrophin in controlling neuronal development and survival, when they are impaired, offering a therapeutic effect. The aim of this study was to evaluate the effects of curcumin in Alzheimer's disease and Depression, which has as its main pathogenesis the reduction of BDNF levels, monoamine levels, increased oxidative stress, inflammation, beta-amyloid aggregation, Tau protein accumulation and aluminum neurotoxicity, verifying its therapeutic capacity. Therefore, a literature review was performed in the Scholar Google, ScienceDirect, and PubMed databases. The data analyzed demonstrated that curcumin supplementation is able to restore BDNF levels in Alzheimer's disease and depression, in addition to modulating monoamines and reducing oxidative stress, inflammation, beta-amyloid aggregation, Tau protein accumulation and aluminum neurotoxicity, improving their symptoms.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Emerging Therapeutic Potential of Fluoxetine on Cognitive Decline in Alzheimer's Disease: Systematic Review
    Bougea, Anastasia
    Angelopoulou, Efthalia
    Vasilopoulos, Efthimios
    Gourzis, Philippos
    Papageorgiou, Sokratis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [42] Alzheimer's disease and depression
    Gallarda, T
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 : 14 - +
  • [43] miRNAs as Therapeutic Tools in Alzheimer's Disease
    Lee, Chang Youn
    Ryu, In Soo
    Ryu, Jin-Hyeob
    Cho, Hyun-Jeong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [44] Insights into lncRNAs in Alzheimer's disease mechanisms
    Li, Dingfeng
    Zhang, Juan
    Li, Xiaohui
    Chen, Yuhua
    Yu, Feng
    Liu, Qiang
    RNA BIOLOGY, 2021, 18 (07) : 1037 - 1047
  • [45] Late-life Depression and Alzheimer Disease. A Potential Synergy of the Underlying Mechanisms
    Leszek, Jerzy
    Trypka, Elzbieta
    Koutsouraki, Euphrosyni
    Michmizos, Dimitrios
    Yarla, Nagendra Sastry
    Tarasov, Vadim V.
    Ashraf, Ghulam Md
    Aliev, Gjumrakch
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (39) : 5389 - 5394
  • [46] Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease
    Reich, Niklas
    Holscher, Christian
    FRONTIERS IN NEUROENDOCRINOLOGY, 2024, 73
  • [47] Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease
    Eddin, Ahmed Noor
    Hamsho, Khaled
    Adi, Ghaith
    Al-Rimawi, Mohammed
    Alfuwais, Mohammed
    Rab, Saleha Abdul
    Alkattan, Khaled
    Yaqinuddin, Ahmed
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [48] Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease
    Echeverria, Valentina
    Zeitlin, Ross
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (07) : 517 - 523
  • [49] Steroids and Alzheimer's Disease: Changes Associated with Pathology and Therapeutic Potential
    Akwa, Yvette
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 29
  • [50] Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease
    Shoaib, Muhammad
    Kamal, Mohammad Amjad
    Rizvi, Syed Mohd Danish
    CURRENT DRUG METABOLISM, 2017, 18 (09) : 842 - 852